Technavio Announces the Publication of its Research Report Global Prostate Cancer Drugs Market 2016-2020
Technavio recognizes the following companies as the key players in the global prostate cancer drugs market: AbbVie, Astellas Pharma, AstraZeneca, Johnson & Johnson, and Sanofi.
Other Prominent Vendors in the market are: Active Biotech, ADC Therapeutics, Advantagene, Advaxis Pharmaceuticals, ANI Pharmaceuticals, ArQule, Athenex Pharmaceuticals, Bavarian Nordic, Bayer HealthCare, BHR Pharma, BMS, Boehringer Ingelheim, Camurus, Cleveland BioLabs, CureVac, Dendreon, Dextech Medical, Eisai, Endo Pharmaceuticals, Ferring Pharmaceutical, Foresee Pharmaceuticals, GlaxoSmithKline, GTx, Innocrin Pharmaceutical, Inspyr Therapeutics, Io Therapeutics, Lidds AB, Merck Group, Myovant Sciences, Northwest Biotherapeutics, Novartis, Nymox Pharmaceuticals, OncoGenex, Oncolytics Biotech, Orion, Pharmamar, Progenics Pharmaceuticals, Sotio, Spectrum Pharmaceuticals, Synta, Takeda Pharmaceuticals, Teva Pharmaceutical, and Tokai Pharmaceuticals.
Browse full report with TOC @ https://marketreportscenter.com/reports/477182/global-prostate-cancer-drugs-market-2016-2020
Commenting on the report, an analyst from Technavios team said: The market has been witnessing a growing popularity for targeted therapies and immunotherapies, owing to their specific mechanism of action. Immunotherapies such as vaccines, and immune checkpoint inhibitors are gaining traction in the market driven by their limited side-effects, and high efficacy.
According to the report, prostate cancer is characterized by an abnormal growth of testosterone (a hormone in the male reproductive system). Therefore, researchers have developed hormone therapies, which act by reducing the amount of testosterone in the body and stops the growth of cancer cells for several years. This development of hormone therapies and subsequent establishment of their clinical profiles have led to increased adoption among physicians.
Further, the report states that in emerging markets, the increasing costs coupled with lack of healthcare infrastructure has hindered the adoption rates of prostate cancer drugs. Most of the patients are unable to invest in these high-cost treatment options and are likely to discontinue these treatment options during the forecast period.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/477182
About Prostate Cancer Drugs
Prostate cancer is the cancer of prostate gland. According to CDC, it is one of the leading cause of cancer death in men across the races in the US. According to the Urology Care Foundation, globally, one in seven men will be diagnosed with the disease. About one in 35 men die due to prostate cancer. Growth in the prostate can be benign or malignant. Prostate cancer cells spread by breaking away from a prostate tumor. They may travel through blood vessels or lymph vessels and reach other parts of the body. The cells that spread might bind to other tissues, form new tumors, and sometimes damage those tissues as well. When prostate cancer cells spread from their original place to another, the new tumor formed also has the same kind of abnormal cells.
Technavios analysts forecast the global prostate cancer drugs market to grow at a CAGR of 9.21% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global prostate cancer drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
Technavio’s report, Global Prostate Cancer Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/477182
Connect for more details:
Market Reports Center